These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36123926)

  • 1. Identification of a novel ubiquitination related gene signature for patients with breast cancer.
    Zheng Y; Lu W; Chen B; Zhao K
    Medicine (Baltimore); 2022 Sep; 101(37):e30598. PubMed ID: 36123926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ubiquitination-related gene classification and a novel ubiquitination-related gene signature for patients with triple-negative breast cancer.
    Zhao K; Zheng Y; Lu W; Chen B
    Front Genet; 2022; 13():932027. PubMed ID: 36685836
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
    Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
    JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
    He M; Hu C; Deng J; Ji H; Tian W
    World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ubiquitination-related risk model for predicting the prognosis and immunotherapy response of gastric adenocarcinoma patients.
    Shao S; Sun Y; Zhao D; Tian Y; Yang Y; Luo N
    PeerJ; 2024; 12():e16868. PubMed ID: 38313020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients.
    Cai H; Chen H; Huang Q; Zhu JM; Ke ZB; Lin YZ; Zheng QS; Wei Y; Xu N; Xue XY
    Pathol Oncol Res; 2021; 27():1609941. PubMed ID: 34776794
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel cell glycolysis related gene signature predicting survival in patients with breast cancer.
    Jiang F; Wu C; Wang M; Wei K; Wang J
    Sci Rep; 2021 Feb; 11(1):3986. PubMed ID: 33597614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Ubiquitin Related Genes Signature for Predicting Prognosis of Prostate Cancer.
    Song G; Zhang Y; Li H; Liu Z; Song W; Li R; Wei C; Wang T; Liu J; Liu X
    Front Genet; 2021; 12():778503. PubMed ID: 35111198
    [No Abstract]   [Full Text] [Related]  

  • 15. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
    Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
    DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the ubiquitination-related molecular classification and signature to predict the survival and immune microenvironment in colon cancer.
    Xu JZ; Wan TQ; Su JS; Song JM
    Front Genet; 2024; 15():1292249. PubMed ID: 39268080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer.
    Li X; Fu S; Huang Y; Luan T; Wang H; Wang J
    BMC Cancer; 2021 Nov; 21(1):1267. PubMed ID: 34819038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.